Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001863662 | SCV002123427 | uncertain significance | not provided | 2023-08-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1353902). This variant has not been reported in the literature in individuals affected with HMCN1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2386 of the HMCN1 protein (p.Ile2386Val). |
Ambry Genetics | RCV004038976 | SCV003709949 | uncertain significance | not specified | 2022-11-21 | criteria provided, single submitter | clinical testing | The c.7156A>G (p.I2386V) alteration is located in exon 46 (coding exon 46) of the HMCN1 gene. This alteration results from a A to G substitution at nucleotide position 7156, causing the isoleucine (I) at amino acid position 2386 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003451988 | SCV004179812 | uncertain significance | Age related macular degeneration 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |